Niu M - Search Results

1

TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy.

Yi M, Li T, Niu M, Wu Y, Zhao Z, Wu K. Yi M, et al. Among authors: niu m. Front Immunol. 2022 Dec 19;13:1061394. doi: 10.3389/fimmu.2022.1061394. eCollection 2022. Front Immunol. 2022. PMID: 36601124 Free PMC article. Review.

2

Upregulation of STAT1-CCL5 axis is a biomarker of colon cancer and promotes the proliferation of colon cancer cells.

Niu M, Yi M, Dong B, Luo S, Wu K. Niu M, et al. Ann Transl Med. 2020 Aug;8(15):951. doi: 10.21037/atm-20-4428. Ann Transl Med. 2020. PMID: 32953751 Free PMC article.

3

CD44 as a tumor biomarker and therapeutic target.

Xu H, Niu M, Yuan X, Wu K, Liu A. Xu H, et al. Among authors: niu m. Exp Hematol Oncol. 2020 Dec 10;9(1):36. doi: 10.1186/s40164-020-00192-0. Exp Hematol Oncol. 2020. PMID: 33303029 Free PMC article. Review.

4

Regulation of PD-L1 expression in the tumor microenvironment.

Yi M, Niu M, Xu L, Luo S, Wu K. Yi M, et al. Among authors: niu m. J Hematol Oncol. 2021 Jan 7;14(1):10. doi: 10.1186/s13045-020-01027-5. J Hematol Oncol. 2021. PMID: 33413496 Free PMC article. Review.

5

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1.

Yi M, Zhang J, Li A, Niu M, Yan Y, Jiao Y, Luo S, Zhou P, Wu K. Yi M, et al. Among authors: niu m. J Hematol Oncol. 2021 Feb 16;14(1):27. doi: 10.1186/s13045-021-01045-x. J Hematol Oncol. 2021. PMID: 33593403 Free PMC article.

6

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.

Niu M, Yi M, Li N, Luo S, Wu K. Niu M, et al. Exp Hematol Oncol. 2021 Mar 2;10(1):18. doi: 10.1186/s40164-021-00211-8. Exp Hematol Oncol. 2021. PMID: 33653420 Free PMC article. Review.

7

Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study.

Yi M, Li T, Niu M, Luo S, Chu Q, Wu K. Yi M, et al. Among authors: niu m. Biomark Res. 2021 Jul 7;9(1):55. doi: 10.1186/s40364-021-00310-y. Biomark Res. 2021. PMID: 34233747 Free PMC article.

8

Advances of Targeted Therapy for Hepatocellular Carcinoma.

Niu M, Yi M, Li N, Wu K, Wu K. Niu M, et al. Front Oncol. 2021 Jul 26;11:719896. doi: 10.3389/fonc.2021.719896. eCollection 2021. Front Oncol. 2021. PMID: 34381735 Free PMC article. Review.

9

Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers.

Yi M, Niu M, Zhang J, Li S, Zhu S, Yan Y, Li N, Zhou P, Chu Q, Wu K. Yi M, et al. Among authors: niu m. J Hematol Oncol. 2021 Sep 15;14(1):146. doi: 10.1186/s13045-021-01155-6. J Hematol Oncol. 2021. PMID: 34526097 Free PMC article.

10

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions.

Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K. Yi M, et al. Among authors: niu m. Mol Cancer. 2022 Jan 21;21(1):28. doi: 10.1186/s12943-021-01489-2. Mol Cancer. 2022. PMID: 35062949 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,722 results

Search Page

Filters